Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia | MicrobiomeTrials← Back to trialsNCT07725575
Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2024-11-01Est. Completion: 2025-04-24
Enrollment target: 86 participants Locations- Cipto Mangunkusumo Hospital, Jakarta, DKI Jakarta, Indonesia
Other microbiome trials you might be interested in
Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia (BPD), or chronic lung disease of prematurity, is the most consequential complication of pret…
Philadelphia, United StatesEst. completion Dec 31, 2028
Bronchopulmonary Dysplasia
Bronchopulmonary dysplasia (BPD) is one of the most common and severe complications of extreme prematurity, affecting ap…
Modena, ItalyEst. completion Feb 2027